LIGAND PHARMACEUTICALS

LGNDNASDAQ

🏆 #1037 by market capEarnings Nov 4US Equity

$326.87▲ $17.06 (+5.22%)

Simulated price

1h—

24h▲ 5.2%

7d—

14d—

30d—

1y—

🏦Market Cap

$5.76B

Small Cap

📈Revenue Growth (YoY)

+51.2%

High Growth

📊Gross Margin

95.3%

High

💵FCF Margin

44.9%

Strong

⚖️P/S Ratio

21.6x

Expensive

Otter Score

64

Fair

Earnings

Q2 · 2026Pre-MarketReported 2026-08-06

Earnings Per Share

Actual

2.37

Expected

1.88

beat

+26.20%

Revenue

Actual

$111.72M

Expected

$61.98M

beat

+80.30%

Consensus estimates